U 37883A

Background and purpose:  Intermedin (IMD) is a newly identified member of the calcitonin family of peptides that shares… Expand

U-37883A (PNU-37883A, guanidine; 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexyl hydrochloride) was originally developed as… Expand

1. Endomorphins 1 and 2, endogenous ligands for the μ‐opioid receptor, and nociceptin (orphanin FQ; OFQ), an endogenous ligand… Expand

Calcium-sensitizing drugs, such as levosimendan, are a novel class of drug therapy for heart failure. We investigated the… Expand

Background: Although a great deal is known about responses to propofol, controversy remains about its mechanism of action. The… Expand

The effects of the vascular selective nonsulfonylurea guanidine ATP-sensitive K+ (KATP+) channel-blocking agent U-37883A on… Expand

The present study investigates the effects of human adrenomedullin (ADM) on the pulmonary vascular bed of isolated, blood… Expand

The activity of potassium uniport in rat liver mitochondria was measured using light scattering technique (mitochondrial swelling… Expand

Follicle-enclosed Xenopus oocytes were used to describe the ATP-sensitive K+ (KATP) channel-blocking properties of U-37883A (4… Expand

This study describes the in vitro and in vivo characteristics of a guanidine 4-morpholinecarboximidine-N-1-adamantyl-N… Expand